Sendi, Pedram; Palmer, Andrew J.; Gafni, Amiram; … - In: PharmacoEconomics 19 (2001) 7, pp. 709-713
The advent of highly active antiretroviral therapy (HAART), including protease inhibitors and/or non-nucleoside reverse transcriptase inhibitors, for the treatment of HIV infection has led to a dramatic decline of morbidity and mortality. The acquisition costs of HAART are substantial. However,...